X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-01-31 | ASH | Novo Guillermo | Chair of the Board, CEO | P - Purchase | $64.24 | +31,294 | 158,032 | +25% | +$2,010,327 | ||||||
2025-01-31 | ASH | Assis Alessandra Faccin | SVP, GM, Life Sciences | P - Purchase | $64.00 | +3,150 | 3,150 | New | +$201,600 | ||||||
2024-12-05 | ASH | Boni Eric N | VP, Finance, Prinpl Acctg Off | S - Sale | $78.07 | -451 | 22,319 | -2% | -$35,210 | ||||||
2024-11-19 | ASH | Lampkin Robin E. | SVP, GC, Secrty. | S - Sale | $75.54 | -162 | 4,184 | -4% | -$12,237 | ||||||
| D | 2024-11-15 | ASH | Lampkin Robin E. | SVP, GC, Secrty. | S - Sale+OE | $77.90 | -868 | 3,713 | -19% | -$67,617 | |||||
| D | 2024-09-04 | ASH | Willis J Kevin | SVP, CFO | S - Sale+OE | $87.88 | -5,487 | 243,778 | -2% | -$482,198 | |||||
2024-02-16 | ASH | Lampkin Robin E. | SVP, GC, Secrty. | S - Sale | $92.54 | -844 | 3,703 | -19% | -$78,104 | ||||||
| D | 2023-12-07 | ASH | Boni Eric N | Principal Accounting Officer | S - Sale+OE | $82.38 | -843 | 20,958 | -4% | -$69,446 | |||||
| D | 2023-09-05 | ASH | Willis J Kevin | Sr.VP,CFO | S - Sale+OE | $86.54 | -7,866 | 230,642 | -3% | -$680,724 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |